OMCL250117P35000
- 0.50
- 0.000.00%
Omnicell Newsroom
BofA Securities Maintains Omnicell(OMCL.US) With Hold Rating, Maintains Target Price $46
Omnicell Is Maintained at Equal-Weight by Wells Fargo
Omnicell Analyst Ratings
Omnicell Is Maintained at Neutral by B of A Securities
Omnicell Analyst Ratings
BofA Securities Maintains Omnicell(OMCL.US) With Hold Rating, Cuts Target Price to $46
Wells Fargo Maintains Omnicell(OMCL.US) With Hold Rating, Maintains Target Price $49
Cautious Outlook on Omnicell: Hold Rating Due to Uncertain Robotic Revenue Growth Amid Job Fluctuations
BofA Securities Maintains Omnicell(OMCL.US) With Hold Rating, Maintains Target Price $54
Piper Sandler Maintains Omnicell(OMCL.US) With Buy Rating, Raises Target Price to $69
Wells Fargo Maintains Omnicell(OMCL.US) With Hold Rating, Maintains Target Price $49
Colliers Securities Initiates Omnicell(OMCL.US) With Buy Rating, Announces Target Price $52
Omnicell Is Maintained at Neutral by JP Morgan
Omnicell Analyst Ratings
J.P. Morgan Maintains Omnicell(OMCL.US) With Hold Rating, Raises Target Price to $44
BofA Securities Maintains Omnicell(OMCL.US) With Hold Rating, Cuts Target Price to $54
BofA Securities Downgrades Omnicell(OMCL.US) to Hold Rating, Raises Target Price to $57
Omnicell Price Target Raised to $58.00/Share From $39.00 by Barclays
Omnicell Is Maintained at Buy by Craig-Hallum
Benchmark Co. Maintains Omnicell(OMCL.US) With Buy Rating, Raises Target Price to $62